British Dragon Exemestane contains Exemestane in oral tablet form, labeled at 25 mg per tablet. For tablet-based aromatase inhibitors, accurate dosing is important to maintain consistency across batches, making independent lab testing a valuable source of verification.
Below is the latest available lab test confirming the potency of Exemestane 25 mg, conducted by a trusted third-party laboratory.
Latest Lab Result (2026)
Janoshik Lab Report – 2026-03-23
- Product: Exemestane
- Active Substance: Exemestane
- Manufacturer: British Dragon
- Labeled Dosage: 25 mg/tablet
- Result: 23.64 mg/tablet
- Laboratory: Janoshik
This lab test shows a measured content of 23.64 mg per tablet, which is slightly below the labeled 25 mg dosage. The result indicates a small negative deviation while remaining relatively close to the intended strength.
Potency Analysis
- Labeled dosage: 25 mg
- Measured dosage: 23.64 mg
- Deviation: ~-5.4%
- Laboratory: Janoshik
The measured result shows a moderate but controlled deviation from the labeled dosage. For tablet-based formulations, this level of variance is not uncommon and still reflects relatively close alignment with the intended strength.
About Exemestane
Exemestane is an aromatase inhibitor commonly produced in oral tablet form. Due to its fixed dosing structure, maintaining consistent active substance content is important for predictable use across batches.
Independent lab testing provides transparency by confirming how closely a specific batch matches its labeled dosage.
Conclusion
The available lab test for British Dragon Exemestane 25 mg shows a measured dosage of 23.64 mg per tablet, slightly below the labeled amount. This result indicates a moderate negative deviation while remaining relatively close to the intended strength.
As only one lab report is currently available, additional testing over time would help determine long-term batch consistency. However, this initial result suggests a generally stable potency profile.
Frequently Asked Questions
The available lab test shows 23.64 mg per tablet, which is slightly below the labeled dosage.
The measured result is approximately 5.4% below the labeled dosage.
The available lab report was conducted by Janoshik, an independent laboratory.
Currently, only one lab test is available. Additional reports would help evaluate consistency across batches.
